Inhibition of HSP90 with NVP-AUY922 induces a synergistic effect in HER2-amplified, trastuzumab-resistant breast and gastric cancer

被引:0
|
作者
Wainberg, Zev A. [1 ]
Rogers, Amy [1 ]
O'Brien, Neil [1 ]
Anghel, Adrian [1 ]
Desai, Amrita [1 ]
Kalous, Ondrej [1 ]
Conklin, Dylan [1 ]
Akimov, Mikhail [2 ]
Finn, Richard S. [1 ]
Slamon, Dennis J. [1 ]
机构
[1] Univ Calif Los Angeles, Med Ctr Santa Monica, Santa Monica, CA USA
[2] Novartis, Basel, Switzerland
关键词
D O I
10.1158/1538-7445.AM2012-3668
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3668
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Inhibition of HSP90 with AUY922 Induces Synergy in HER2-Amplified Trastuzumab-Resistant Breast and Gastric Cancer
    Wainberg, Zev A.
    Anghel, Adrian
    Rogers, Amy M.
    Desai, Amrita J.
    Kalous, Ondrej
    Conklin, Dylan
    Ayala, Raul
    O'Brien, Neil A.
    Quadt, Cornelia
    Akimov, Mikhail
    Slamon, Dennis J.
    Finn, Richard S.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (04) : 509 - 519
  • [2] The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells
    Canonici, Alexandra
    Qadir, Zulfiqar
    Conlon, Neil T.
    Collins, Denis M.
    O'Brien, Neil A.
    Walsh, Naomi
    Eustace, Alex J.
    O'Donovan, Norma
    Crown, John
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (04) : 581 - 589
  • [3] The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells
    Alexandra Canonici
    Zulfiqar Qadir
    Neil T. Conlon
    Denis M. Collins
    Neil A. O’Brien
    Naomi Walsh
    Alex J. Eustace
    Norma O’Donovan
    John Crown
    Investigational New Drugs, 2018, 36 : 581 - 589
  • [4] Novel Hsp90 Inhibitor NVP-AUY922 Radiosensitizes Prostate Cancer Cells
    Gandhi, N.
    Wild, A. T.
    Aziz, K.
    Chettiar, S.
    Gajula, R.
    Zeng, J.
    Herman, J.
    Deweese, T. L.
    Hales, R.
    Tran, P. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S178 - S178
  • [5] Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
    Gandhi, Nishant
    Wild, Aaron T.
    Chettiar, Sivarajan T.
    Aziz, Khaled
    Kato, Yoshinori
    Gajula, Rajendra P.
    Williams, Russell D.
    Cades, Jessica A.
    Annadanam, Anvesh
    Song, Danny
    Zhang, Yonggang
    Hales, Russell K.
    Herman, Joseph M.
    Armour, Elwood
    DeWeese, Theodore L.
    Schaeffer, Edward M.
    Tran, Phuoc T.
    CANCER BIOLOGY & THERAPY, 2013, 14 (04) : 347 - 356
  • [6] Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
    Bao, Xiao-Hong
    Takaoka, Munenori
    Hao, Hui-Fang
    Fukazawa, Takuya
    Yamatsuji, Tomoki
    Sakurama, Kazufumi
    Takigawa, Nagio
    Nakajima, Motowo
    Fujiwara, Toshiyoshi
    Naomoto, Yoshio
    ONCOLOGY REPORTS, 2013, 29 (01) : 45 - 50
  • [7] Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90αRadiosensibilisierender Effekt des neuartigen Hsp90-Inhibitors NVP-AUY922 in Hsp90α-inhibierten humanen Tumorzelllinien
    L. Stingl
    N. Niewidok
    N. Müller
    M. Selle
    C.S. Djuzenova
    M. Flentje
    Strahlentherapie und Onkologie, 2012, 188 (6) : 507 - 517
  • [8] Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90α
    Stingl, L.
    Niewidok, N.
    Mueller, N.
    Selle, M.
    Djuzenova, C. S.
    Flentje, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (06) : 507 - 515
  • [9] NVP-AUY922:: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
    Jensen, Michael Rugaard
    Schoepfer, Joseph
    Radimerski, Thomas
    Massey, Andrew
    Guy, Chantale T.
    Brueggen, Josef
    Quadt, Cornelia
    Buckler, Alan
    Cozens, Robert
    Drysdale, Martin J.
    Garcia-Echeverria, Carlos
    Chene, Patrick
    BREAST CANCER RESEARCH, 2008, 10 (02)
  • [10] Targeting HSP90 by the Novel Inhibitor NVP-AUY922 Reduces Growth and Angiogenesis of Pancreatic Cancer
    Moser, Christian
    Lang, Sven A.
    Hackl, Christina
    Wagner, Christine
    Scheiffert, Eva
    Schlitt, Hans J.
    Geissler, Edward K.
    Stoeltzing, Oliver
    ANTICANCER RESEARCH, 2012, 32 (07) : 2551 - 2561